Entrepreneurs
For Entrepreneurs
Looking for investors can be both exciting and nerve-wracking. We want to help make it as smooth as possible for you. Here’s what you need to know so you can be ready for a great Angel relationship with ATA.
2027 Ata Submission Deadlines to Be Considered for the Following Month:
Applications submitted by these dates will be considered for the Screening Meeting which takes place early the following month. There is no Screening Meeting in December.
| Month | Due Date |
|---|---|
| January | 12/31/2026 |
| February | 1/31/2027 |
| March | 2/28/2027 |
| April | 3/29/2027 |
| Month | Due Date |
|---|---|
| May | 4/30/2027 |
| June | 5/31/2027 |
| July | 6/28/2027 |
| August | 7/31/2027 |
| Month | Due Date |
|---|---|
| September | 8/31/2027 |
| October | 9/30/2027 |
| November | 10/26/2027 |
| January | 2028 |
Atlanta Technology Angels Investment Criteria
Types of Companies
We invest in technology-oriented businesses with the potential to scale rapidly and with capital efficiency.
Geography
We work with companies based in the Southeast, especially in the greater Atlanta area.
Company Stage
ATA members invest primarily in startups that have moved beyond the concept and early prototype stages and are demonstrating customer validation.
Minimum: Working product with meaningful customer testing underway.
Preferred: Beta or commercially launched product with pilots, paid pilots, or early customers.
Ideal: Fully developed product with initial revenue and demonstrated customer demand.
Exception: For companies developing products that require FDA approval, ATA members will consider companies at an earlier stage when funding will support required clinical testing, regulatory approval, and commercialization.
Management Team
We’re looking for talented management teams that demonstrate vision, focus, and the ability to execute. Prior CEO and domain experience are big pluses.
Fundraising Round
We do 6-8 deals per year. We invest between $100k-$300k in deals. This means:
- We lead rounds of $300k – $750k. Typically a convertible note with 6% interest, 20% discount, and a valuation cap between $2M – $12M.
- We participate in a variety of “angel deals” if you already have a lead investor and defined terms.
- We can also fill out priced rounds of various sizes and security types if you have a lead investor and 75% of the target round committed.
Industries
We’re interested in companies that leverage technology to create disruption. For medical device and biotech companies, we prefer products and services with a clear regulatory path. We generally do not invest in pharmaceuticals.
For Entrepreneurs
Looking for investors can be both exciting and nerve-wracking. We want to help make it as smooth as possible for you. Here’s what you need to know so you can be ready for a great Angel relationship with ATA.
2027 Ata Submission Deadlines to Be Considered for the Following Month.
Applications submitted by these dates will be considered for the Screening Meeting which takes place early the following month. There is no Screening Meeting in December.
| Month | Due Date |
|---|---|
| January | 12/31/2026 |
| February | 1/31/2027 |
| March | 2/28/2027 |
| April | 3/29/2027 |
| May | 4/30/2027 |
| June | 5/31/2027 |
| July | 6/28/2027 |
| August | 7/31/2027 |
| September | 8/31/2027 |
| October | 9/30/2027 |
| November | 10/26/2027 |
| January | 2028 |

Atlanta Technology Angels Investment Criteria
Types of Companies
We invest in technology-oriented businesses with the potential to scale rapidly and with capital efficiency.
Geography
We work with companies based in the Southeast, especially in the greater Atlanta area.
Company Stage
ATA members invest primarily in startups that have moved beyond the concept and early prototype stages and are demonstrating customer validation.
Minimum: Working product with meaningful customer testing underway
Preferred: Beta or commercially launched product with pilots, paid pilots, or early customers.
Ideal: Fully developed product with initial revenue and demonstrated customer demand.
Exception: For companies developing products that require FDA approval, ATA members will consider companies at an earlier stage when funding will support required clinical testing, regulatory approval, and commercialization.
Management Team
We’re looking for talented management teams that demonstrate vision, focus, and the ability to execute. Prior CEO and domain experience are big pluses.
Fundraising Round
We do 6-8 deals per year. We invest between $100k-$300k in deals. This means:
- We lead rounds of $300k – $750k. Typically a convertible note with 6% interest, 20% discount, and a valuation cap between $2M – $12M.
- We participate in a variety of “angel deals” if you already have a lead investor and defined terms.
- We can also fill out priced rounds of various sizes and security types if you have a lead investor and 75% of the target round committed.
Industries
We’re interested in companies that leverage technology to create disruption. For medical device and biotech companies, we prefer products and services with a clear regulatory path. We generally do not invest in pharmaceuticals.
Submission & Application Screening Process
Our application process is designed to simplify company and deal evaluations. Please submit a confidential pre-screening application below!
From Entrepreneurs

Atlanta Technology Angels Pre-Screening Applications
All ATA Pre-Screening Applications MUST be submitted to us via this link.
NOTE: Do not include confidential information. Neither ATA nor its members sign Non-Disclosure Agreements for initial proposals. If there is sufficient interest, an NDA may be negotiated with individual members at a later time

